BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-09-13 | Pages: 200+ | Report ID: WR-2024-09-13-49543 | Pharmaceutics
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Biosimilar Testing and Development Services Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET
7.1 GLOBAL BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Eurofins Scientific
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Medistri
16.3 Pharmaceutical Product Development
16.4 SGS
16.5 Intertek Group
16.6 Charles River Laboratories
16.7 Sigma-Aldrich
16.8 Source BioScience
16.9 Exova
16.10 Pace Analytical Services
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Market by Type :Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Market by Application :
PK assay
Tiered Immunogenicity testing
NAb assays
Companies
Eurofins Scientific
Medistri
Pharmaceutical Product Development
SGS
Intertek Group
Charles River Laboratories
Sigma-Aldrich
Source BioScience
Exova
Pace Analytical Services
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.